Dr. Kashani is an Associate Professor of Ophthalmology at the Wilmer Eye Institute of Johns Hopkins School of Medicine. He is a Board Certified Ophthalmologist and vitreoretinal surgeon. Over the past decade, he has designed and implemented numerous clinical studies aimed at improving the diagnosis and management of retinal vascular diseases through use of innovative imaging methods. His lab is funded by the NIH and was one of the few sites where preclinical studies were performed for clinical implementation of OCT Angiography technology before it was first FDA approved in 2015. Since that time he has been a leader in the clinical implementation of OCT Angiography to study, diagnose and help treat retinal vascular diseases. He has published numerous studies demonstrating the utility of OCTA in assessing retinal capillary loss in subjects with Diabetic Retinopathy, Retinal Venous Occlusion and inflammatory diseases of the eye. Recently, he has received funding from the NINDS to lead a consortium of universities in implementing OCT Angiography in the diagnosis of retinal changes that accompany neurodegenerative diseases causing dementia. Dr. Kashani is the Principal Investigator of a novel, first-in-man Phase 1/2a clinical trial assessing the safety and efficacy of a stem cell-derived retinal pigment epithelium implantation for treatment of severe vision loss from dry age related macular degeneration.